Sylvester Turner served two terms as mayor before winning the 18th district congressional seat in Texas last November, which ...
Phase Ib trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL), aiming to reshape the standard-of-care landscape.
A new study from researchers at the Oregon Health and Science University (OHSU) proposes a test called PAC-MANN, which could ...
Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...
According to the American Cancer Society, people diagnosed with pancreatic cancer have a 13% chance of living five years ...
Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm: CANTA) today announced that Damian Marron, Interim CEO, will participate at the H.C.
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.